GH Research

Compare

287 Followers

GHRS Stock Chart & Stats

$14.32

-$0.22(-2.41%)

At close: Jan 08 4:00 PM EST

$14.32

-$0.22(-2.41%)

Day’s Range― - ―

52-Week Range$6.72 - $20.50

Previous CloseN/A

Volume14.35K

Average Volume (3M)296.66K

Market Cap

$865.29M

Enterprise Value$465.24M

Total Cash (Recent Filing)$291.54M

Total Debt (Recent Filing)$647.00K

Price to Earnings (P/E)―

Beta0.88

Next Earnings

Nov 06, 2025

EPS Estimate

-0.24

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.15

Shares Outstanding62,028,145

10 Day Avg. Volume274,564

30 Day Avg. Volume296,658

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market Cap0.54

Enterprise Value/RevenueN/A

Enterprise Value/Gross Profit-3.02K

Enterprise Value/Ebitda-11.49

Forecast

1Y Price Target

$29.67

Price Target Upside107.19% Upside

Rating ConsensusStrong Buy

Number of Analyst Covering7

Bulls Say, Bears Say

Bulls Say

Clinical DataThe final Phase 2b trial and open-label extension data confirm a differentiated profile—rapid onset, 73% six-month remission with infrequent visits, and clean safety.

Financial OutlookGH001 is estimated to be a significant opportunity with potential sales of $1.9 billion in the US by 2035.

Regulatory ProgressResolution of the FDA hold could lift an important overhang on GHRS, providing potential upside for the company.

Bears Say

Due Diligence IssuesThe company acknowledges difficulty in performing due diligence regarding addressing the FDA's outstanding concern.

FDA DelaysFDA requested additional data and further justification on rat respiratory histology findings, delaying progress.

Regulatory ChallengesClinical risks such as functional unbinding and single dose durability remain ahead of Phase 3 trials.

GH Research News

Psychedelic: Needham initiates coverage of atai, GH Research, MindMed

In this week’s “Psychedelic,” The Fly’s recurring series focused on psychedelic stock news, The Fly looks back on...

12d ago

ABBV

ATAI

GH Research initiated with a Buy at Needham

Needham initiated coverage of GH Research (GHRS) with a Buy rating and $19 price target The company’s GH001...

15d ago

GHRS

Psychedelic: PharmAla launches portal for MDMA prescribers, therapists

In this week’s “Psychedelic,” The Fly’s recurring series focused on psychedelic stock news, The Fly looks back on...

19d ago

GHRS

SILO

GH Research’s GH001 Trial Results to be Presented at ACNP Meeting

The latest announcement is out from GH Research ( ($GHRS) ). GH Research PLC announced the acceptance of...

11d ago

GHRS

GH Research Unveils Promising GH001 Trial Data at ECNP 2025

An announcement from GH Research ( ($GHRS) ) is now available. GH Research PLC presented data from its...

14d ago

GHRS

GH Research Presents Promising GH001 Trial Data at ECNP 2025

GH Research ( ($GHRS) ) just unveiled an update. GH Research PLC announced the presentation of data from...

18d ago

GHRS

GH Research Showcases Promising Depression Treatment at ECNP 2025

GH Research ( ($GHRS) ) has issued an update. GH Research PLC announced its participation in the 38th...

19d ago

GHRS

GH Research to Join TD Cowen Neuropsychiatry Summit

GH Research ( ($GHRS) ) has issued an update. GH Research PLC announced its participation in a fireside...

2M ago

GHRS

GH Research Presents Promising Trial Results for GH001 at ISBD 2025

GH Research ( ($GHRS) ) has issued an update. GH Research PLC announced the presentation of data from...

2M ago

GHRS

GH Research PLC to Engage Investors at Cantor Global Healthcare Conference

GH Research ( ($GHRS) ) just unveiled an announcement. GH Research PLC announced its participation in the upcoming...

2M ago

GHRS

Psychedelic: Exclusive talk with biopharma company Reunion Neuroscience

In this edition of “Psychedelic”, The Fly conducted an exclusive interview with Greg Mayes, President and Chief Executive...

2M ago

ATAI

CMND

Buy Rating for GH Research Driven by Promising TRD Program Developments and Regulatory Progress

H.C. Wainwright analyst Patrick Trucchio has reiterated their bullish stance on GHRS stock, giving a Buy rating on...

3M ago

GHRS

GH Research’s Strategic Progress and Financial Stability Earns Buy Rating from Ritu Baral

TD Cowen analyst Ritu Baral has maintained their bullish stance on GHRS stock, giving a Buy rating yesterday....

3M ago

GHRS

Psychedelic: Cybin receives European approval for EMBRACE study

In this week’s “Psychedelic,” The Fly’s recurring series focused on psychedelic stock news, The Fly looks back on...

3M ago

CMND

CMPS

GHRS FAQ

What was GH Research’s price range in the past 12 months?

GH Research lowest stock price was $6.72 and its highest was $20.50 in the past 12 months.

What is GH Research’s market cap?

GH Research’s market cap is $865.29M.

When is GH Research’s upcoming earnings report date?

GH Research’s upcoming earnings report date is Nov 06, 2025 which is in 9 days.

How were GH Research’s earnings last quarter?

GH Research released its earnings results on Aug 07, 2025. The company reported -$0.15 earnings per share for the quarter, beating the consensus estimate of -$0.214 by $0.064.

Is GH Research overvalued?

According to Wall Street analysts GH Research’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does GH Research pay dividends?

GH Research does not currently pay dividends.

What is GH Research’s EPS estimate?

GH Research’s EPS estimate is -0.24.

How many shares outstanding does GH Research have?

GH Research has 62,028,145 shares outstanding.

What happened to GH Research’s price movement after its last earnings report?

GH Research reported an EPS of -$0.15 in its last earnings report, beating expectations of -$0.214. Following the earnings report the stock price went down -0.412%.

Which hedge fund is a major shareholder of GH Research?

Currently, no hedge funds are holding shares in GHRS

GH Research Stock Smart Score

Outperform

Fundamentals

Return on Equity

-16.35%

Trailing 12-Months

Asset Growth

51.43%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

GH Research

GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies for the treatment of psychiatric and neurological disorders. The company focuses on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). Its lead program is GH001, an inhalable 5-MeO-DMT product candidate that has completed two Phase 1 clinical trials and Phase 1/2 clinical trial in patients with TRD. The company also develops GH002, an injectable 5-MeO-DMT product candidate; and GH003, an intranasal 5-MeO-DMT product candidate, which are in preclinical development trials with a focus on psychiatric and neurological disorders. GH Research PLC was incorporated in 2018 and is based in Dublin, Ireland.

GH Research (GHRS) Earnings & Revenues

Historic Earnings Reports

GHRS Stock 12 Month Forecast

Average Price Target

$29.67

▲(107.19% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"6":"$6","41":"$41","14.75":"$14.75","23.5":"$23.5","32.25":"$32.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":40,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$40.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":29.67,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$29.67</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":19,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$19.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[6,14.75,23.5,32.25,41],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2025","6":"Apr<br/>2025","9":"Jul<br/>2025","12":"Oct<br/>2025","25":"Oct<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,13.57,15.603076923076923,17.636153846153846,19.669230769230772,21.70230769230769,23.735384615384618,25.76846153846154,27.801538461538463,29.834615384615386,31.86769230769231,33.90076923076923,35.933846153846154,37.96692307692308,{"y":40,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,13.57,14.80846153846154,16.04692307692308,17.285384615384615,18.523846153846154,19.762307692307694,21.00076923076923,22.23923076923077,23.47769230769231,24.716153846153848,25.954615384615387,27.193076923076923,28.431538461538462,{"y":29.67,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,13.57,13.987692307692308,14.405384615384616,14.823076923076924,15.240769230769232,15.65846153846154,16.076153846153847,16.493846153846153,16.911538461538463,17.32923076923077,17.74692307692308,18.164615384615384,18.582307692307694,{"y":19,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":10.5,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.15,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.68,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.6,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.13,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.76,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.77,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.56,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.72,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.74,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.93,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.57,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >